financetom
Business
financetom
/
Business
/
AGCO Q1 Adjusted Net Income, Net Sales Fall -- Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AGCO Q1 Adjusted Net Income, Net Sales Fall -- Shares Rise
May 25, 2025 11:22 PM

09:32 AM EDT, 05/01/2025 (MT Newswires) -- AGCO ( AGCO ) reported Q1 adjusted net income Thursday of $0.41 per share, down from $2.32 a year earlier.

Analysts polled by FactSet expected $0.04.

Net sales for the quarter ended March 31 were $2.05 billion, down from $2.93 billion a year earlier.

Analysts surveyed by FactSet expected $2.05 billion.

The company said it continues to expect full-year 2025 EPS in the range of $4 to $4.50 on net sales of about $9.60 billion. Analysts polled by FactSet expect EPS of $3.51 on revenue of $9.48 billion.

Shares rose over 10% in recent trading activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Super Micro Computer Unusual Options Activity
Super Micro Computer Unusual Options Activity
May 20, 2024
Deep-pocketed investors have adopted a bearish approach towards Super Micro Computer ( SMCI ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SMCI usually suggests something big is about to happen. We gleaned this...
Arrowhead Pharmaceuticals Lung Disease Treatment Study Shows Lower Serum sRAGE in Asthma Patients
Arrowhead Pharmaceuticals Lung Disease Treatment Study Shows Lower Serum sRAGE in Asthma Patients
May 20, 2024
11:04 AM EDT, 05/20/2024 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Monday that a study of its investigational RNAi-based medicine for inflammatory lung disease treatment showed lower serum soluble receptors for advanced glycation end-products, or sRAGE, in asthma patients. Interim data from the ongoing phase 1/2 study showed that serum sRAGE was cut by up to 88% after...
What's Going On With Faraday Future Stock Today?
What's Going On With Faraday Future Stock Today?
May 20, 2024
Faraday Future Intelligent Electric Inc. ( FFIE ) shares are trading higher Monday as the retail-fueled rally in heavily-shorted stocks returns. What To Know: Faraday Future's stock ran up more than 8000% last week and reached an intraday high of $3.90 Friday before reversing to close in the red for the session.   Retail traders appear to be back in the...
Accenture Unit Closes Cognosante Acquisition
Accenture Unit Closes Cognosante Acquisition
May 20, 2024
11:03 AM EDT, 05/20/2024 (MT Newswires) -- Accenture ( ACN ) unit Accenture Federal Services said Monday it has closed its acquisition of Cognosante, which provides digital transformation and cloud modernization technology for federal health, defense, intelligence, and civilian agencies. Financial terms of the deal weren't disclosed. Accenture Federal Services said that with the acquisition, it is establishing a new...
Copyright 2023-2026 - www.financetom.com All Rights Reserved